Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Hangzhou Tigermed Consulting Co Ltd (3347) operate in?
Hangzhou Tigermed Consulting Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Hangzhou Tigermed Consulting Co Ltd (3347) current stock price?
As of the latest data, Hangzhou Tigermed Consulting Co Ltd stock price is HK$45.84, with a previous close of HK$46.34. Hangzhou Tigermed Consulting Co Ltd lost -HK$0.50 in the last trading session, representing a -1.08% loss.
What is Hangzhou Tigermed Consulting Co Ltd (3347) current market capitalization?
Hangzhou Tigermed Consulting Co Ltd market cap is approximately 5.64 billion.
What is Hangzhou Tigermed Consulting Co Ltd (3347) Earnings Per Share (EPS)?
The trailing EPS is HK$0.07, and the forward EPS is HK$1.66.
What is Hangzhou Tigermed Consulting Co Ltd (3347) Price-to-Earnings (P/E) ratio?
Hangzhou Tigermed Consulting Co Ltd current P/E ratio is 634.02, with a forward P/E of 27.57.
What is Hangzhou Tigermed Consulting Co Ltd (3347) EBITDA?
Hangzhou Tigermed Consulting Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 187.38 million.
Does Hangzhou Tigermed Consulting Co Ltd (3347) pay dividends?
Yes. Hangzhou Tigermed Consulting Co Ltd pays semiannual dividends with an annualized yield of 1.42% and an estimated annual payout of HK$0.65 per share.
When is the next ex-dividend date for Hangzhou Tigermed Consulting Co Ltd (3347)?
The next ex-dividend date is scheduled for December 12, 2025.
How did Hangzhou Tigermed Consulting Co Ltd (3347) perform in its most recent earnings report?
In the last report (June 30, 2025), Hangzhou Tigermed Consulting Co Ltd posted an EPS surprise of -44.73% and a revenue surprise of -12.93%.
When is Hangzhou Tigermed Consulting Co Ltd (3347) next earnings report?
Hangzhou Tigermed Consulting Co Ltd is expected to release its next earnings report on September 30, 2025.
What is Hangzhou Tigermed Consulting Co Ltd (3347) beta (volatility) score?
Hangzhou Tigermed Consulting Co Ltd has a beta of 0.831, meaning its volatility is roughly in line with the market.
